首页> 美国卫生研究院文献>Biochemical Journal >Some high-performance liquid-chromatographic studies of the metabolism of aflatoxins by rat liver microsomal preparations.
【2h】

Some high-performance liquid-chromatographic studies of the metabolism of aflatoxins by rat liver microsomal preparations.

机译:大鼠肝微粒体制剂对黄曲霉毒素代谢的一些高效液相色谱研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The metabolism of aflatoxin B1 in vitro was examined in rat liver microsomal preparations. 2. H.p.l.c. (high-performance liquid-chromatographic) systems were used. A silica column was used to separate non-polar metabolites. A system utilizing a reversed-phase column which separates both poar and non-polar metabolites was also developed. 3. The principal metabolites of aflatoxin B1 found were aflatoxin M1, aflatoxin Q1 and a compound which co-chromatographed with a degradation product of aflatoxin B1 2,3-dihydrodiol. 4. The time course of metabolism of aflatoxin B1 by microsomal preparations isolated from control and phenobarbitone-pretreated rats was examined. The rate and extent of metabolism was greater with microsomal preparations from the latter. The formation of aflatoxin Q1 was enhanced 4--5-fold by phenobarbitone pretreatment, whereas the production of aflatoxin M1 was only increased 1--2-fold. The formation of the degradation product of aflatoxin B1 2,3-dihydrodiol was increased 4--5-fold by the pretreatment with phenobarbitone. 5. The microsomal metabolism of aflatoxins M1, P1 and Q1 was examined. Aflatoxin M1 apparently underwent very limited microsomal metabolism to more polar compounds. Aflatoxin P1 was not metabolized. The situation with aflatoxin Q1 was complicated in that it was metabolized in the absence of NADPH to an unidentified metabolite. Aflatoxin B1 appeared as a metabolite of aflatoxin Q1 only when NADPH was present, and the formation of more polar metabolites was also then observed.
机译:在大鼠肝微粒体制剂中检查了黄曲霉毒素B1的体外代谢。 2. H.p.l.c. (高性能液相色谱)系统被使用。硅胶柱用于分离非极性代谢物。还开发了一种利用反相色谱柱分离极性和非极性代谢产物的系统。 3.发现的黄曲霉毒素B1的主要代谢产物是黄曲霉毒素M1,黄曲霉毒素Q1和与黄曲霉毒素B1 2,3-二氢二醇的降解产物共色谱的化合物。 4.检查了从对照和苯巴比妥预处理的大鼠中分离的微粒体制剂黄曲霉毒素B1代谢的时间过程。后者的微粒体制剂的代谢速率和程度更高。黄曲霉毒素Q1的形成通过苯巴比妥预处理提高了4--5倍,而黄曲霉毒素M1的生成仅增加了1--2-倍。通过用苯巴比妥预处理,黄曲霉毒素B1 2,3-二氢二醇的降解产物的形成增加了4-5倍。 5.检查了黄曲霉毒素M1,P1和Q1的微粒体代谢。黄曲霉毒素M1显然经历了非常有限的微粒体代谢,以生成更多极性化合物。黄曲霉毒素P1不被代谢。黄曲霉毒素Q1的情况很复杂,因为它在不存在NADPH的情况下被代谢成未知的代谢物。仅当存在NADPH时,黄曲霉毒素B1才作为黄曲霉毒素Q1的代谢物出现,然后还观察到更多极性代谢物的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号